Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04132141 · ClinicalTrials.gov registry record · NA

VR Breaks on Shift-worker Alertness

A NA study, sponsored by George Washington University.

Terminated
Registry status
NA
Development phase
25
Enrollment target

NCT04132141: Clinical Trial NA study, sponsored by George Washington University.

NCT04132141 is a NA study that was terminated before completion, run by George Washington University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04132141, a NA study, was terminated before completion, sponsored by George Washington University.

TERMINATED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Physician wellness is a hot topic today. Fatigue and alertness are common challenges faced during long work hours. Virtual reality is an immersive technology which has been demonstrated to distract people from pain, stress, and anxiety. Guided relaxation and meditation can impact alertness. There is no literature reporting the impact immersive technologies like VR sessions could have on alertness, a critical area of concern in health care today which impacts physician wellness, quality of care, and duty hours. The investigator's long-term goal is to develop solutions that can be used across industries to improve human alertness. To solve this problem, the investigators propose to test the feasibility of using an immersive virtual reality experience as a scheduled break and measure the interventions effect on post-break alertness, stress, and anxiety. Previous work at our Institution has demonstrated that VR experiences can reduce pain, stress and anxiety in patients presenting to the emergency department.

Primary Outcome

response time measure of alertness using PVT software

Interventions

  • OTHER Virtual Reality Headset with curated content

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-09-23
Est. Completion 2020-02-27
Phase NA
George Washington University

133 total trials

Why NCT04132141 stopped before completion

NCT04132141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Headset with curated content is the first listed.

NCT04132141 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04132141 about?

NCT04132141 is a clinical study titled "VR Breaks on Shift-worker Alertness". Physician wellness is a hot topic today. Fatigue and alertness are common challenges faced during long work hours. Virtual reality is an immersive technology which has been demonstrated to distract people from pain, stress, and anxiety. Guided relaxation and meditation can impact alertness. There is...

What is the current status of trial NCT04132141?

This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2019-09-23. Estimated completion is 2020-02-27.

What interventions are being tested in trial NCT04132141?

The interventions under investigation include: Virtual Reality Headset with curated content (OTHER).

Who is sponsoring clinical trial NCT04132141?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04132141's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04132141, the US trial registry maintained by the National Library of Medicine. NCT04132141 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.